NCT05473091

Brief Summary

Liver abnormalities are common in Turner syndrome. The physiopathology of these abnormalities is unknown for the moment but their potentially serious evolution requires additional explorations.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
179

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 11, 2022

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 11, 2022

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

July 22, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 25, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2022

Completed
Last Updated

October 30, 2023

Status Verified

October 1, 2023

Enrollment Period

Same day

First QC Date

July 22, 2022

Last Update Submit

October 27, 2023

Conditions

Turner Syndrome

Outcome Measures

Primary Outcomes (1)

  • pro inflammatory score

    18 years

Study Arms (2)

Experimental group

Other: no intervention

Control group

Other: no intervention

Interventions

no interventionOTHER

retrospective analysis

Control groupExperimental group

Eligibility Criteria

Age18 Years - 56 Years
Sexfemale
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Retrospective analysis of data from patients followed in the Service of Endocrinology, Diabetology and Nutrition, University Hospital of Nancy

You may qualify if:

  • Turner syndrome
  • healthy subjects

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHUR de Nancy

Nancy, France

Location

MeSH Terms

Conditions

Turner Syndrome

Condition Hierarchy (Ancestors)

Gonadal DysgenesisDisorders of Sex DevelopmentUrogenital AbnormalitiesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesSex Chromosome Disorders of Sex DevelopmentMale Urogenital DiseasesHeart Defects, CongenitalCardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesSex Chromosome DisordersChromosome DisordersGenetic Diseases, InbornGonadal DisordersEndocrine System Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

July 22, 2022

First Posted

July 25, 2022

Study Start

March 11, 2022

Primary Completion

March 11, 2022

Study Completion

September 1, 2022

Last Updated

October 30, 2023

Record last verified: 2023-10

Locations

FR(1)